Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Covella Pharmaceuticals

2007 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of bio-technical services. The company engages in providing VLA-1 neutralizing antibodies for the multiple inflammatory and autoimmune diseases.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • DE
  • United States

Covella Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Covella Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Covella Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Mark Totoritis MD Co-Founder
Matthew Strobeck Ph.D Co-Founder

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »